Sensei Biotherapeutics appoints Josiah Craver as principal financial officer

Sensei Biotherapeutics, Inc.

Craver appointed principal financial and accounting officer effective Sept 17, 2024; previously SVP Finance since July 2024.
Base salary $360,000, annual bonus target 35%, and stock option for 80,000 shares vesting over 4 years.
Severance: six months salary if terminated without cause/good reason; 12 months salary plus bonus and equity acceleration upon change in control.
David Gaiero ceased serving as interim principal financial and accounting officer immediately.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

David Gaiero

interim principal financial officer and principal accounting officer

SNSE · Sensei Biotherapeutics, Inc.

Effective: 2024-09-17
Successor: Josiah Craver
Filed: September 20, 2024, 7:59 PM ET

In connection with such appointment, David Gaiero, who was serving as the Company’s principal financial officer and principal accounting officer on an interim basis, ceased serving in such capacities as of the Effective Date.

Appointed

Josiah Craver

principal financial officer and principal accounting officer

SNSE · Sensei Biotherapeutics, Inc.

Effective: 2024-09-17
Filed: September 20, 2024, 7:59 PM ET

On September 17, 2024, the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) appointed Josiah Craver as the Company’s principal financial officer and principal accounting officer, effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Gaiero departed as interim principal financial officer and principal accounting officer at Sensei Biotherapeutics, Inc..

Action: ceased serving
Role: interim principal financial officer and principal accounting officer

Exact text from the filing

In connection with such appointment, David Gaiero, who was serving as the Company’s principal financial officer and principal accounting officer on an interim basis, ceased serving in such capacities as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Josiah Craver was appointed as principal financial officer and principal accounting officer at Sensei Biotherapeutics, Inc..

Action: appointed
Role: principal financial officer and principal accounting officer

Exact text from the filing

On September 17, 2024, the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) appointed Josiah Craver as the Company’s principal financial officer and principal accounting officer, effective immediately

View on SEC.gov

Sensei Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-222937

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.